That’s a good question. I don’t know if there’s a direct connection between Otto and Alice but odds are they either know each other personally or are aware of each other’s work and standing.

I’m hoping that once it’s known that leronlimab is effective, whether that be at the next interim or at full enrollment, Yang will be a strong advocate for its widespread use.

Yang has been very careful and guarded in his comments on the efficacy of leronlimab thus far, which is appropriate, but I get the impression that once the trials show meaningful results, he will be fully on board in pushing for an approval.